Targeting Molecular Pathways in Breast Cancer Using Plant-Derived Bioactive Compounds: A Comprehensive Review

Itqan Athaya Al Khalily1, Sandra Megantara2, Diah Lia Aulifa2

  • 1Master Program in Pharmacy, Faculty of Pharmacy, Padjadjaran University, Sumedang, West Java, 45363, Indonesia.

Insights

Natural compounds from medicinal plants show promise as safer breast cancer treatments. Further research into advanced formulations could enhance their clinical use and improve patient outcomes.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Breast cancer is a leading global health concern with current treatments causing significant side effects.
  • There is a growing need for safer and more effective breast cancer therapies.
  • Medicinal plants offer a source of bioactive compounds with potential anti-cancer properties.

Purpose of the Study:

  • To review the potential of natural compounds from medicinal plants as alternative breast cancer treatments.
  • To explore the mechanisms of action of these compounds against key cancer pathways.
  • To discuss challenges and future directions for the clinical application of plant-based therapies.

Main Methods:

  • Literature review of computational, in vitro, and in vivo studies.
  • Analysis of bioactive compounds like flavonoids, alkaloids, and phenolics.
  • Examination of targeted cancer pathways including EGFR, PI3K/AKT/mTOR, and NF-κB.

Main Results:

  • Plant-derived compounds demonstrate efficacy in inhibiting tumor growth and inducing cancer cell death.
  • Bioactive compounds target critical cancer signaling pathways.
  • Flavonoids, alkaloids, and phenolics show significant therapeutic potential.

Conclusions:

  • Natural compounds offer a promising avenue for developing less toxic breast cancer treatments.
  • Overcoming challenges in absorption, stability, and formulation is key for clinical success.
  • Integrating plant-based therapies with conventional treatments could improve patient outcomes.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...